BFA
SGYP

BlackRock Fund Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Fund Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$60.2M Buy
9,881,438
+955,911
+11% +$5M 0.01% 1561
2016
Q3 		$49.2M Buy
8,925,527
+100,978
+1% +$473K 0.01% 1594
2016
Q2 		$33.5M Buy
8,824,549
+3,120,748
+55% +$10.6M 0.01% 1743
2016
Q1 		$15.7M Buy
5,703,801
+392,916
+7% +$1.42M ﹤0.01% 2104
2015
Q4 		$30.1M Sell
5,310,885
-219,031
-4% -$1.34M 0.01% 1797
2015
Q3 		$29.3M Buy
5,529,916
+1,588,633
+40% +$12.3M 0.01% 1761
2015
Q2 		$32.7M Buy
3,941,283
+93,318
+2% +$452K 0.01% 1798
2015
Q1 		$17.8M Buy
3,847,965
+65,468
+2% +$213K ﹤0.01% 2131
2014
Q4 		$11.5M Buy
3,782,497
+367,352
+11% +$1.09M ﹤0.01% 2377
2014
Q3 		$9.51M Sell
3,415,145
-3,353
-0.1% -$12.2K ﹤0.01% 2377
2014
Q2 		$13.9M Buy
3,418,498
+49,571
+1% +$211K ﹤0.01% 2220
2014
Q1 		$17.9M Buy
3,368,927
+89,806
+3% +$503K 0.01% 2058
2013
Q4 		$18.2M Sell
3,279,121
-20,897
-0.6% -$90.1K 0.01% 2042
2013
Q3 		$14.9M Buy
3,300,018
+417,641
+14% +$1.87M 0.01% 2122
2013
Q2 		$12.3M Buy
+2,882,377
New +$14.5M ﹤0.01% 2147

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock Fund Advisors's SGYP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 11% in Q4 2016, buying an estimated $5M and bringing the position to 9,881,438 shares worth $60.2M. The position accounts for 0.01% of the portfolio, ranked #1561.

BlackRock Fund Advisors first reported a position in SGYP in Q2 2013 and has held it in 15 quarters since. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • BlackRock Fund Advisors held 9,881,438 shares of Synergy Pharmaceuticals, Inc Common Stock worth $60.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 955,911 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $5M.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1561 holding.
  • BlackRock Fund Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and has held it in 15 quarters since.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.